Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

AARTI PHARMALABS LTD.

NSE : AARTIPHARMBSE : 543748ISIN CODE : INE0LRU01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE674.1042.35 (+6.7 %)
PREV CLOSE () 631.75
OPEN PRICE () 649.55
BID PRICE (QTY) 672.20 (51)
OFFER PRICE (QTY) 673.80 (1)
VOLUME 31874
TODAY'S LOW / HIGH ()636.30 674.10
52 WK LOW / HIGH ()380.65 721
NSE655.8523.5 (+3.72 %)
PREV CLOSE() 632.35
OPEN PRICE () 647.00
BID PRICE (QTY) 655.80 (100)
OFFER PRICE (QTY) 655.85 (486)
VOLUME 744183
TODAY'S LOW / HIGH() 636.10 658.00
52 WK LOW / HIGH ()399.55 721.7
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2019

Management Info :

Rashesh C Gogri - Chairman Narendra J Salvi - Managing Director

Registered Office :

Address : Plot No. 22/ C/1 & 22/ C/2,1st Phase, G. I. D. C.,Valsad,
Vapi,
Gujarat-396195

Phone : 0260 2400467 / 09909994655

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
17Dec Aarti Pharmalabs informs about disclos
Aarti Pharmalabs has informed that the Company has received from Constit..
13Dec Aarti Pharmalabs informs about outcome
Aarti Pharmalabs has informed that the Board of Directors has, at its me..
13Dec Appointment of Director
Inter alia, based on the recommendation of the Nomination and Remunerat..
29Oct Aarti Pharmalabs informs about press r
Aarti Pharmalabs has informed that the Standalone and Consolidated Audit..
08Oct Aarti Pharmalabs informs about certifi
Aarti Pharmalabs has informed that it enclosed a Certificate under Regul..
Financials
in Millions
QTR Sep 24 ANNUAL 24
Net Profit478.3699999999992006.5
Gross Profit 634.339999999999 2745.2
Operating Profit 877.1999999999993571.6
Net Sales 3772.9415021.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 29394.75 (2.66%)
M.Cap ( in Cr)
62643.69
Neuland Laboratories (BSE)
 13553.05 (0.80%)
M.Cap ( in Cr)
17436.40
Alkem Laboratories (BSE)
 5463.55 (1.09%)
M.Cap ( in Cr)
65324.94
Akums Drugs & Pharmaceuticals (BSE)
 661.50 (8.91%)
M.Cap ( in Cr)
10368.33
Ajanta Pharma (BSE)
 2846.10 (1.82%)
M.Cap ( in Cr)
35639.92
Shareholding Pattern
PROMOTERS 46.1%
NON-INSTITUTION 35.16%
FI/BANKS/INSURANCE 6.09%
MUTUAL FUNDS/UTI 4.93%
GOVERNMENT 0.01%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX78977.85505.37 (0.64%)
NIFTY23920.35170.15 (0.72%)
Dow Jones 43325.8028.77 (0.07%)
Nasdaq 20020.36-10.77 (-0.05%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI